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ABSTRACT
The purpose was to characterize the postoperative outcome of patients with vestibular
schwannoma (VS) by evaluating especially postoperative headache, contralateral hearing loss,
hearing preservation and recovery of postural stability. Altogether 384 VS patients in Helsinki
University Central Hospital were included in the study in addition to a survey on 97 patients
operated on at Sahlgrenska Hospital, Gothenburg, Sweden.
Almost 60% of the VS patients suffered from headache after surgery. One year later
headache persisted in 40% and it was more common among those with also preoperative headache.
If headache continued for one year, it tended to be permanent. The most important risk factor for
headache was retrosigmoid (RS) operation. No single mechanism for postoperative headache was
found. However, a sumatriptan trial suggested that vascular structures may be involved in at least
some cases.
After translabyrinthine (TL) operation contralateral hearing loss starting few week after
surgery, was observed in 6% of the patients. After RS operation 1.8% of the patients developed a
significant contralateral hearing loss which started after two to four years.
Hearing was preserved in 40% of the patients. Sixty-six per cent of these patients
considered the preserved hearing a success, although in only 10 patients the preserved hearing was
better than 30 dB. Tinnitus did not interfere with speech understanding.
Subjectively 31% of the patients had problems with gait, but based on measurements of
postural stability deterioration occurred in 68% of the patients. The impairment of postural stability
was usually slight. Most patients had good postural stability with eyes open, but with eyes closed
the postural stability was poor. Advanced age, depression and the RS approach were risk factors
for postoperative gait problems. Also female gender had a negative influence on recovery. Elderly
patients had increased risk for poor vestibular compensation after surgery.
In conclusion, postoperative headache, although probably multietiological, may be caused
by trigeminal neuropathy in the posterior fossa, where pain afferents trigger abnormal reflexes
analogously with local vascular headache. If postoperative headache has continued for more than
one year no significant reduction in the maximum pain intensity can be expected. The usefulness of
preserved hearing was better than predicted and surgeons should continue to preserve hearing in
VS surgery. Vestibular habituation therapy increased the use of proprioception and improved
postural stability.
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1.  INTRODUCTION
Vestibular schwannoma (VS), previously called acoustic neuroma and neurinoma, is a benign
growth of the eighth nerve sheath. The growth rate of VS is characteristically slow. The first
symptom is usually a hearing loss indicating damage to the cochlear nerve and it may be due to
tumor compression or invasion (Tos et al. 1998, Selesnick and Jackler 1992, Matsunaga et al.
1995). Vertigo is seldom present (Selesnick and Jackler 1992, Tos et al. 1998). The treatment of
VS is mainly surgical, although other alternatives, such as stereotactic radiation therapy and
conservative management also exist.
Figure 1. Arthur af Forselles (1864-1953),
the first Professor of oto-rhino-laryngology
in Helsinki University Central Hospital.
In 1913 af Forselles (Fig. 1) performed the first successful VS removal in Finland (af
Forselles 1916). Two years after operation the patient was able to work although he had total facial
paralysis and spontaneous nystagmus to the right. Historically, discussion of postoperative
morbidity focused on complications such as meningitis, cerebrospinal fluid leak, intracranial
hemorrhage, cerebral vascular accidents and brain compression injuries (Dandy 1934, Horrax and
Poppen 1939, Driscoll et al. 1998). After the development of surgical technique postoperative
mortality has decreased below 2%, facial nerve preservation has became routine and even hearing
preservation is obtained in selected cases. The quality of life after surgery has become an issue and
questions such as hearing preservation, tinnitus, dysequilibrium, headache, damage to the facial
nerve and depression have arisen (Parving et al. 1992, Driscoll et al. 1998).
The object of the present work was to characterize the postoperative outcome and in
particular the following aspects: 1. headache, 2. contralateral hearing loss, 3. hearing preservation
and 4. postural stability.
2.  REVIEW OF THE LITERATURE
2.1.  Tumor characteristics
Epidemiology. VS is reported to occur in all races (Lanser et al. 1992). The tumor accounts for 6
to 10% of all primary intracranial tumors (Shiffman et al. 1973, Nager 1985, Tos et al. 1998), and
for about 71 to 90% of all cerebellopontine angle tumors (Nager 1985, Tos et al. 1998). The
incidence of occult VS estimated from autopsies of asymptomatic cases is about 1% (Karjalainen et
al. 1984), but the real incidence of  VS has been debated (Nestor et al. 1988, Lanser et al. 1992),
and can even be lower (Selesnick et al. 1999). Tos et al. (1999) found a gradual increase in clinical
incidence of VS during the last 20 years, which can be due to better diagnostic tools. The majority
of the tumors were microscopic without clinical significance. Tos et al. (1999) suggest that the
clinical incidence is 7.8 to 12.4 tumors per million per year.
Most commonly VS occurs during the fourth and fifth decades of life (Shiffman et al.
1973), and it is about two times as common in females as in males (Nager 1985). There are two
distinct clinical presentations: sporadic unilateral VS and hereditary bilateral VS. Sporadic VS does
not result in development of other tumors within the CNS or in transmission of the disease to the
proband’s offspring (Lanser et al. 1992). Bilateral schwannoma of the internal auditory canal (IAC)
usually manifests itself during the second or third decade of life (Shiffman et al. 1973), and is often
an expression of neurofibromatosis 2 (NF2) (Tos et al. 1998). NF2 is an autosomal dominantly
inherited disorder with a high degree of penetrance, which predisposes to the development of
vestibular schwannomas (usually bilateral) to affected individuals; schwannomas of the other
cranial, spinal or peripheral nerves; meningiomas, both intracranial and intraspinal; and some low
grade central nervous system malignancies (ependymomas, gliomas) (Evans et al. 1999). Bilateral
tumors account for about 4-5% of all VS (Nager 1985, Evans et al. 1999).
Neurofibromatosis 1 (NF1) or von Recklinghausen’s neurofibromatosis, a separate genetic
disease resembling NF2, extremely rarely causes VS (Lanser et al. 1992, Tos et al. 1998).
Pathogenesis. VS is a benign growth of the eighth nerve sheath, an overproliferation of Schwann
cells, usually beginning along the vestibular nerve within the IAC at the junction of peripheral and
central myelin sheath (Shiffman 1973). VS is initially located in the vestibular division of the eighth
nerve in the IAC in the majority of the cases (Henschen 1916, Ylikoski et al. 1978, Nager 1985,
Rhoton and Tedeschi 1992).
VS is a slowly growing neoplasm and insidiously progressive in its development (Shiffman
1973). The tumor growth varies between -0.3 (shrinking) to 20 mm per year (Kawamoto et al.
1995), and is generally slow (Lesser et al. 1991). The progression of VS growth may be extremely
difficult to determine (Lanser et al. 1992), as the VS may be dormant for several years and then
grow rapidly. The growth has been categorized into one of three growth patterns: slow, medium
and fast (Lanser et al. 1992). According to Rosenberg (2000) the vast majority of VS patients over
65 years of age have an overall growth rate of 0.9 mm per year when followed with MRI scans,
and therefore these patients do not require intervention.
The growth of VS may affect all four nerves (the facial, the superior and the inferior
vestibular, and the cochlear nerves) and blood vessels within the IAC (Shiffman 1973). In the
beginning the tumor mechanically displaces the nerves and the vessels that are ultimately flattened
against the canal walls. The expanding tumor widens or erodes the canal, and a portion of the
tumor spills out of the porus and into the cerebellopontine angle. If the tumor growth progresses,
the tumor finally contacts cranial nerves V and VI in the anteromedial direction and cranial nerves
IX, X and XI in the inferior direction. The tumor compromises cerebrospinal fluid circulation when
it compresses the cerebellum and the brain stem. Tumor infiltration of the cochlear nerve has also
been verified (Ylikoski et al 1978), although some suggest (Perre et al. 1990) that only
neurofibromas, not schwannomas, infiltrate the cochlear nerve.
The typical sporadic unilateral tumor with expansive growth affects adversely the cochlear
nerve by compression (Lanser et al. 1992). With NF2 patients the tumors tend to be more
aggressive and will often infiltrate adjacent nerves (Lanser et al. 1992).
Bilateral eighth nerve tumors differ from unilateral ones in several ways. Bilateral lesions
obviously reveal a multicentric growth pattern (Nager 1985), which reflects more often a fast
growth pattern (Lanser et al. 1992). They can reach a remarkable size and can cause severe
compression of the brain stem. The bony changes are also more extensive, and the tumor tends to
invade the pneumatic cells and marrow spaces.
Histopathology. VSs are generally well demarcated and encapsulated, with a pale color and a firm
consistence initially (Nager 1985). The color and consistency of the tumor varies with the amount
of regressive changes (Nager 1985). Schwannomas are comprised of streams of elongated spindle
cells, somewhat fibrous in appearance, and arranged into a characteristic palisade (Shiffman 1973),
fascicle, stream or loop pattern (Nager 1985).
Within the VS there can be distinguished two types of tissue: a dense, cellular, fibrillar
structure of the tissue type “A“ of Antoni, and a loose, less cellular, reticular structure of the tissue
type “B“ of Antoni (Nager 1985). The histologic distinction of these two cell types is of no known
clinical significance (Lanser et al. 1992). Regions of Antoni A and B may coexist within the same
tumor.
Genetics. Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder associated with
bilateral VS. NF2s comprise about 5% of all VSs (Lanser et al. 1992). About half of the NF2s are
sporadic and half of them are dominantly inherited. The genetic locus of NF2 has been localized in
the long arm of chromosome 22 (22q) (Rouleau et al 1987, Keiser-Kupfer et al. 1989). The
diagnosis of NF2 has been based on finding bilateral tumors of the 8th cranial nerves in MRI. The
gene defect is in chromosome 22 and is called NF2-gene which is also a tumor growth suppressing
gene (Seizinger et al. 1987). It is distinguished from NF1 where the gene defect is in chromosome
17 (Seizinger et al. 1987). NF1 presents with multiple peripheral neurofibromas with frequent cafe-
au-lait spots on the skin. NF1 is not linked to vestibular schwannomas, except in some rare cases
(Sadeh et al. 1989). Thus, it seems likely that VSs are all linked to the NF2 gene either by sporadic
mutation or inherited defect of chromosome 22. Both NF1 and NF2 can also present with other
tumors within the central nervous system (CNS) with somewhat different predilections. Thus NF2
has frequently been combined with meningiomas, fifth cranial nerve gliomas, intramedullary
astrocytomas and spinal neurofibromas (Riccardi 1981, Evans et al. 1998).
NF2 was probably first reported by Wishart (1820) in a case with multiple intracranial
tumors without cutaneous involvement but later confounded with findings of cases with both skin
lesions and central nervous system tumors (see Evans et al. 1992). In the 1970's the distinction
between the two types of neurofibromatosis (NF1 and NF2) became accepted (Kanter et al. 1980,
Riccardi 1981). Subsequent studies have shown that patients with NF1 do not have an increased
frequency of vestibular schwannomas when compared to the normal population (Evans et al.
1998). A further effort to separate the NF2 from the usual acoustic neuroma was made by the
National Institute Health Consensus Conference (Dec. 1991) where the NF2 tumors were
considered histologically analogous to schwannomas of the vestibular nerve. The conference
recommended replacing the term acoustic neuroma in NF2 by VS.
Chromosome 22 and NF2-gene locus
Figure 2. Flanking markers indicating location of NF2-gene in chromosome 22. (Sainio et al.
1995).
The location of the genetic defect of NF2 in the long arm of chromosome 22 lies in the
vicinity of the meningioma translocation braking point and the crystalline gene (Fig. 2). The
spontaneous mutation rates and the braking point in the long arm produce various subtypes of the
disorders, some with frequent meningiomas, spinal tumors and posterior capsular cataracts, and
some without these signs. Based on clinical observations two subtypes have been proposed: the so
called Gardner and Wishart types (Evans et al. 1999). The Gardner type shows a relatively benign
course and mainly bilateral schwannomas whereas the Wishart type shows early onset, rapid course
and multiple other tumors in addition to bilateral VS (Evans et al. 1999).
2.2.  Symptoms
Symptoms of VS have been known for over 150 years (Lanser et al. 1992). VS is commonly
associated with hearing loss, but may manifest with other symptoms, too, which depend on the site
of the origin and the growth pattern of the tumors (Tos et al. 1998).
Hearing loss. Hearing loss is the most common symptom of VS. It was the first symptom in 75%
of the patients according to Thomsen and Tos (1990) as well as Rosenberg (2000). Hearing loss
develops gradually over months or years and manifests as a high frequency unilateral sensorineural
hearing loss (Thomsen and Tos 1990). It is associated with impairment of speech discrimination
more than expected from the level of hearing loss (Johnson 1977, Schuknecht and Woellner 1955).
Among patients with sudden sensorineural hearing loss only 2 to 5% have CPA tumors (Saunders
et al. 1995, Doyle 1999), but among patients with VS, from 10 to 26% have had sudden hearing
loss (Higgs 1973, Selesnick et al. 1993). According to Selesnick and Jackler (1993) in 15% of
patients with VS hearing was subjectively normal at the time of the diagnosis, but only 4% had
normal hearing in pure tone audiometry.  Thomsen and Tos (1990) recorded in 3 % the patients
with VS normal hearing in audiometry at the time of the diagnosis. According to Selesnick et al.
(1993) the incidence of hearing loss as a complaint increased with the size of the tumor: 77% with
the tumor less than 1 cm, 88% with the tumor 1 - 3 cm and 95% with the tumor larger than 3 cm.
The average duration of hearing loss was 3.9 years before diagnosis.
The exact mechanism causing hearing loss in VS is not certain, but compression of the
cochleovestibular nerve by the tumor and compromise of the blood supply to the nerve or to the
cochlea are possible explanations (Perre et al. 1990). Compression varies with the tumor growth
rate, the location of the tumor within the IAC, and the neural origin of the tumor (Perre et al.
1990). Vascular compromise can lead to either gradual or sudden hearing loss, whereas
compression of the cochleovestibular nerve may lead to gradual hearing loss (Higgs 1973, Perre et
al 1990). Vascular compromise of the cochlear nerve by the tumor mass or hemorrhage seems to
be the mechanism behind sudden hearing loss in VS (Higgs 1973), which was a presenting
symptom in 8.2% to 13.8% of the patients (Rosenberg 2000).
Tinnitus. Tinnitus is commonly present in VS and may vary in character. It is very seldom the
reason for the investigations, and is often overshadowed by the hearing loss (Mathew et al. 1978).
Rosenberg (2000) found tinnitus present in 10.2 to 17.5% of cases. According to Parving et al.
(1992) 62% of the patients complained of tinnitus. Tinnitus was present in 53% of the patients with
small tumors, in 59% of those with medium size tumors and in 52% of those with large tumors. It
was an early symptom in 36% of the patients, but seldom the sole initial symptom (Selesnick et al.
1993). From a database of 174 patients having unilateral tinnitus only one VS was detected
according to Dawes and Basiouny (1999). The mechanisms for tinnitus are thought to be the same
as those for hearing loss: neural compression or vascular derangement (Selesnick et al. 1993).
Vertigo. Vertigo can be described as an illusion of motion (Stewart et al. 1999) and it usually
occurs relatively early in the clinical course of VS, and after lasting for days or weeks then
spontaneously resolves (Selesnick and Jackler 1992). As vertigo resolves, dysequilibrium, a sense
of floating or unsteadiness, may begin (Selesnick and Jackler 1992). Symptoms are usually mild or
moderate in intensity but rarely disabling. Severe vestibular symptoms begin relatively late in the
course of the tumor growth and tend to be continuous and unremitting (Selesnick et al. 1993).
Rosenberg (2000) found dysequilibrium present in 20% to 30.7% of the cases and vertigo in 16%
of the cases. Fifty-seven percent of the patients had experienced dysequilibrium before surgery
according to Parving et al (1992). Selesnick et al. (1993) found 48% of the patients having
experienced dysequilibrium: it was present in 37% of the patients with tumor less than 1 cm, in
47% of the 1 to 3 cm tumors and in 71% of the tumors larger than 3 cm.
The etiology of vertigo is most probably tumor infiltration or compression of the vestibular
nerve, or compromise of vascular structures or the cerebellum. The distortion of vestibular
information from the side of the tumor is gradually compensated for (Magnusson et al. 1992).
Cerebellar dysfunction. Cerebellar dysfunction is usually caused by gradual lateral compression
(Selesnick and Jackler 1992), so midline structures of the cerebellum are rarely involved. Cerebellar
symptoms are manifested as incoordination, ataxia, or dysequilibrium. Cerebellar dysfunction can
cause dysequilibrium alone or in combination with vestibular function loss (Selesnick and Jackler
1992). Symptoms begin late in the course of tumor growth. Thomsen and Tos (1990) found
cerebellar dysfunction in as many as 45% of the patients, but Rosenberg (2000) in 1.3% to 14.3%
of the patients.
Trigeminal nerve dysfunction. Trigeminal dysfunction appears as hypoesthesia or paresthesia,
most frequently in the midfacial region (Selesnick et al. 1993). It is thought that the earliest
trigeminal symptom is the absence of the corneal reflex. Further progression leads to midfacial
tingling followed by upper and lower face tingling (Selesnick and Jackler 1992). Facial pain may
occur but is unusual (Snow and Frazer 1987).
In one series the incidence of trigeminal sensory symptoms was 20% of the patients and
was dependent on tumor size (Selesnick et al. 1993). No patients with tumor less than 1 cm had
trigeminal symptoms, whereas 20% with tumor of 1 to 3 cm and 48% with the tumor larger than 3
cm had trigeminal symptoms. Trigeminal nerve dysfunction was the initial symptom in 3% of the
patients (Selesnick et al. 1993). Thomsen and Tos (1990) found the trigeminal nerve affected in
28% of the patients, and in tumors larger than 4 cm 53% were affected. Trigeminal nerve
symptoms are thought to arise secondary to compression of the nerve in the CPA between the
superior aspect of the nerve and tentorium (Selesnick and Jackler 1992).
Headache. Classically cephalalgia secondary to an intracranial lesion is constant, dull, diffuse pain
that is gradual in onset and is usually apparent late in the course of the tumor growth as a sequel of
hydrocephalus (Selesnick and Jackler 1992). Headache due to VS occurs in a minority of the
patients. Pain is often found to be worst in the morning and precipitated by head motion and
exertion (Edwards and Patterson 1951).
In one study headache was present in 19% of the patients and the frequency increased as
the tumor size increased (Selesnick et al. 1993). Patients with tumor less than 1 cm had no
headache, with tumor size 1 to 3 cm 20% had headache and when the tumor was larger than 3 cm
43% of the patients had headache.
Headache, nausea, vomiting, decreased visual acuity, diplopia, anosmia, and obtundation
are associated with increased intracranial pressure. They may occur late in the case of a large
tumor, tend to be gradual in onset, and are persistent (Selesnick and Jackler 1992). Selesnick et al.
(1993) found 4% of VS patients having hydrocephalus at the time of diagnosis, and none of them
complained of headache.
Facial nerve dysfunction. Facial nerve dysfunction is rare. It manifests gradually, late in the
course of the tumor growth, and is rarely seen with small or medium size tumors (Selesnick and
Jackler 1992). Dysfunction can be either hypofunction, manifested as facial weakness, and/or
hyperfunction, manifested as facial twitch or spasms. Selesnick et al. (1993) found facial nerve
dysfunction in 10% of the patients with no relationship to tumor size. It was present in 7% of
patients with small tumors, in 11% of patients with medium tumors, and in 10% of patients with
large tumors. The average duration of facial nerve dysfunction was 0.6 years prior to diagnosis,
and it was present as an initial symptom in only 2% of patients. Thomsen and Tos (1990) found
involvement of the intermedius nerve in 48% of patients. In their study facial nerve function was
normal in 89%. Syms III et al. (1997) found normal facial nerve function in 96% of the patients.
Cranial nerve IX-XI palsies and long tract signs. Clinically palsies of cranial nerves IX-XI
present as dysarthria, dysphagia, aspiration, or hoarseness. Long tract signs present as ipsilateral
lower or upper extremity dysfunction. These lower cranial nerve palsies and long tract signs rarely
occur in VS (Selesnick et al. 1993).
Asymptomatic tumors. A new asymptomatic group of patients with VS has appeared when the
MRI has been taken for other reasons (Selesnick et al. 1999). With widespread use of MRI
asymptomatic VSs are occasionally found (Anderson et al. 2000).
2.3.  Diagnosis
In 1917 when Cushing reviewed his first series of VS, the landmarks for assessing VS were the
history of unilateral hearing loss, cerebellar signs, and physical examination (Cushing 1917). At that
time audiometry was in its infancy. Cushing employed caloric testing with visual inspection on his
patients and found that 83% had evidence of vestibular dysfunction (Cushing 1917). He also noted
that all the patients had either marked hearing loss or complete deafness and frequently tinnitus. Af
Forselles (1916) described a patient with tinnitus in the right ear for 8 years, diplopia since the
previous spirng, headache more on the right side for 3 months, both hearing loss and vision
deterioration on the right, dysequilibrium for one month, stiffness on the right side of the face, and
during the last 3 weeks also digestion problems and vomiting. Af Forselles found trigeminal
hypoesthesia, facial paralysis and hearing loss in the right, and spontaneous nystagmus both to the
left and right. The Caloric test to the right ear gave no reaction, the Romberg test was unstable, the
tongue deviated to the right and the sensitivity was also reduced in the right side of the tongue. The
diagnosis was tumor of the acoustic nerve.
2.3.1.  Audiologic assessment
Pure tone audiogram and speech discrimination. In pure tone audiometry the hearing loss in
VS can be described by the shape of the audiogram: flat or high-tone loss (Selesnick and Jackler
1992). Usually hearing loss in VS is characterized by poor speech discrimination (Johnson 1977,
Schuknecht and Woellner 1955).
Auditory brain stem response. Auditory brain stem response (ABR) is the most reliable
audiologic examination in assessing VS (Ramsden 1995, Doyle 1999). The auditory stimulus elicits
through the auditory pathway distinct but weak electrical activation waves that are hidden behind
normal brain activity. The characteristic ABR waveform is amplified, filtered, and averaged over a
time period. Electrical activity from the auditory nerve is represented in waves I and II. Waves III
and V represent presumably synchronous discharge from the cochlear nuclei and the inferior
colliculus in the midbrain. Waves III and V are the largest and most reliable waveforms in clinical
use. Wave amplitude, latency, and interval between ears are the characteristics commonly
measured. The interaural wave I-V latency differences are the most reliable parameters in the
diagnosis of CPA tumors. When one ear has normal hearing and the hearing in the ear on the side
of the tumor is better than 50 dB at 4 kHz, the normal difference is less than 0.2-0.3 msec (Doyle
1999). Small VS may be associated with normal ABR in 10% to 30% of patients. (Doyle 1999).
Thus, ABR was the most accurate of the noninvasive tests in screening for VS before the
development of magnetic resonance imaging (MRI)  (Brackmann 1999). Robinette et al. (2000)
recommend the use of ABR together with MRI, which allows considerable savings if the patient
has a low risk for VS.
2.3.2.  Vestibular assessment
Selesnick and Jackler (1992) found spontaneous nystagmus uncommon among patients with VS.
The pathology of unilateral involvement can be localized with the caloric tests if it is abnormal.
Today, when even nonsymptomatic small tumors are discovered, ENG abnormalities are no longer
a golden standard for assessing VS (Daniels et al. 1996).
Other vestibular tests are available at present, such as the head autorotation test, the
rotatory chair tests, and the posturography test (O’Leary et al 1991, Johansson et al 1995). These
tests evaluate simultaneously the function of both vestibular organs and have limited value in
localizing unilateral CPA tumors (Selesnick and Jackler 1992).
2.3.3.  Imaging
Roentgen introduced diagnostic imaging in 1895, and Henschen (1910) was the first to use it to
detect the erosion of the porus acusticus (Selesnick and Jackler 1992).
Computerized tomography (CT) was previously used as a reliable examination (Curtin and
Hirsch 1992), but contrast medium is needed to detect a tumor on CT because of the minimal
density differences between the VS and brain tissue (Curtin and Hirsch 1992). With intravenous
contrast medium approximately 70% of VS can be detected with CT. Intracanalicular VS are
difficult to detect even after contrast injection, since bone and enhancing tumor tissue are
essentially equally dense. Only tumors projecting more than 5 mm into the CPA are regularly
detected (Brackmann 1999). The reliability of CT is reduced in the CPA due to artifacts from the
surrounding bony structures. MRI is today the standard in  assessing patients with possible VS
(Brackmann 1999, Doyle 1999). On MRI the VS has the same density as brain tissue. MRI is
superior to CT because on MRI bony structures appear black and cause less artifacts. The VS
enhances intensely with contrast medium, such as gadolinium, and thus virtually all tumors larger
than 2 mm, including those in the IAC, appear brightly white against black bone or (on T1
weighted images) black cerebrospinal fluid (CSF) (Doyle 1999, Brackmann 1999).
2.4.  Treatment
History. The first successful removal of an acoustic tumor was accomplished by either Sir Charles
Ballance in 1891 or Thomas Annandale in 1895 (Cushing 1917, Ramsden 1995). In the absence of
histologic evidence the exact nature of either of the tumors is not known. At the turn of the century
Horsely had a series of six surgically treated acoustic tumors and at least one of the patients made
an excellent recovery (House and Graham 1973). Krause described unilateral suboccipital (SO)
craniectomy in 1903 (Krause 1903, Krause 1906). In 1904 Panse suggested an approach through
the labyrinth, that could be the more direct route to the tumor, because it avoided some of the
problems associated with cerebellar exposure (Panse 1904). Only a few successes were recorded
because of the difficulty in controlling bleeding, the inability to cope with cerebellar swelling, and
the limitations imposed by the size of the opening of the skull itself (House and Graham 1973).
In 1917 Cushing described the bilateral suboccipital approach, in which the posterior fossa
was widely exposed (Cushing 1917). By carrying out a subtotal enucleation of the tumor and using
wide bony decompression of the posterior fossa he was able to reduce surgical mortality to 10%.
Dandy reintroduced in 1925 a concept of unilateral exposure of the cerebellopontine angle using a
bilateral suboccipital craniectomy as proposed earlier by Krause (Dandy 1925) with even lower
mortality rates than Cushing.
2.4.1.  Surgery
Retrosigmoid (suboccipital) surgery. The retrosigmoid approach to the posterior fossa is a
modification of the neurosurgical suboccipital craniotomy or craniectiomy (for review see Cohen,
1992). It gives a wide view of the posterior fossa. The approach was traditionally performed at the
sitting position, but has undergone many modifications.
Retrosigmoid approach (Cohen 1992). During the operation the patient is in the supine position,
with the head turned away from the operator. The skin incision is based anteriorly and centered at
the approximate location of the transverse sinus. After craniotomy, which measures 3 to 5 cm, is
performed, an anteriorly based dural flap is incised exposing the cerebellum. The cerebellum
generally tends to fall away from the tumor, allowing the opening into the cerebellopontine
cistern, with release of cerebrospinal fluid.
The cerebellum is then retracted medially to expose the tumor. The tumor may be
decompressed with the use of an ultrasonic aspirator, if it is bulky. In the case of intracanalicular
tumor when cerebellar retraction is minimal, the tumor can usually be excised in one piece. If
necessary the tumor is dissected off the cerebellum and brain stem depending on the size of the
tumor. The facial nerve can be identified near or at the brain stem. Every attempt is made not to
open the posterior semicircular canal or vestibule if hearing preservation is a goal. Up to 7 mm
of the posterior IAC wall can generally be removed without endangering the posterior
semicircular canal. It is usually possible to recognize the lateral end of the tumor. It is important
also to drill superior and inferior to the canal to expose the circumference of the canal, leaving
only the anterior wall intact. This allows much easier and less traumatic dissection of the tumor
off the nerves.
Dissection of the lateral end of the tumor should reveal the origin from the superior or
inferior vestibular nerve. When the vestibular nerves are cut laterally, a plane is established
between the tumor and the facial nerve superiorly and the cochlear nerve inferiorly. Dissection
can proceed either from lateral to medial or medial to lateral. A plane is developed between the
tumor and the cochlear nerve and dissection proceeds to remove the entire tumor with
preservation of both facial and cochlear nerves.
Translabyrinthine surgery. Approaches to the cerebellopontine angle through the temporal bone
had been advocated already in 1904 by Panse (House and House 1964). The route is generally
called translabyrinthine since it passes through the mastoid and the labyrinth. In 1964 House
reported 54 patient cases of whom 41 underwent the translabyrinthine approach. The
translabyrinthine approach is the most direct route to the CPA. Large tumors can be resected
through the translabyrinthine approach (Jackler 1994). Sacrifice of residual hearing is a
disadvantage of this approach. This method seemingly has the lowest mortality, approximately
0.4%, and possibly also the lowest morbidity (Brackmann and Green 1992).
Translabyrinthine approach (House and House 1964, Brackmann and Green 1992). In the
translabyrinthine approach the patient is placed in the supine position with the head turned to the
opposite side. A complete mastoidectomy is performed down to the level of the horizontal
semicircular canal after which labyrinthectomy is begun. The opening along the superior petrosal
sinus is gradually deepened and widened until the labyrinthine bone is encountered. The lateral
and posterior semicircular canals are progressively removed, and the facial nerve, which lies
anteriorly, is carefully approached. The superior semicircular canal is followed to its ampulla.
The vestibule is opened, and the facial nerve skeletonized from the genu inferiorly to near the
stylomastoid foramen. The skeletonizing is done from the posterior direction allowing access to
the CPA.
Dissection of bone surrounding the IAC is started after the labyrinthine bone has been
removed to the level of the vestibule. It is started along the superior petrosal sinus and gradually
enlarged in all directions toward the IAC. The dura is identified posteriorly. Dissection is carried
inferior to the labyrinth until the blueness of the dome of the jugular bulb is seen through the
overlying bone.
The vestibular aqueduct and the beginning of the endolypmhatic sac are encised and bone
is further removed along the posterior fossa dura beneath the sigmoid sinus. After the cochlear
aqueduct is identified, bone removal is continued around the IAC to the porus acusticus until the
entire posterior lip of the IAC is removed. The bone of the posterior fossa dura is removed
inferiorly until the sigmoid sinus is skeletonized. Dura is opened anterior to the sigmoid sinus in
front of the IAC.
Dissection is carried superiorly and anteriorly around the IAC leaving facial nerve intact.
The superior lip of the porus acusticus is removed, but nor entirely. Dissection of the lateral end
of the IAC begins inferiorly. The transverse crest is identified. After the dissection around the IAC
is completed, the posterior fossa dura is opened to expose the CPA.
The dura is incised over the midpoint of the IAC. The vessels on the surface of the tumor
are avoided. The tumor removal can begin intracapsularly to reduce the tumor size if the tumor is
large, and if no nerve bundles are inspected on the posterior surface. During intracapsular
removal extensive movement of and pressure on the tumor must be avoided, to avoid injury to the
facial nerve.
After the inferior end of the tumor has been gutted the surface of the capsule is followed to
the brain stem. Inferiorly the IXth cranial nerve and often large vessels are localized. They are
separated from the tumor capsule. The plane of the facial nerve is established at the lateral end of
the IAC. The facial nerve can often be followed without difficulties even past the area of
adhesions.
After the facial nerve has been separated from the tumor all the way to the brain stem, the
bulk of the tumor is removed, leaving only a small bulk attached to the brain stem, which is them
removed.
Middle cranial fossa surgery. The middle cranial fossa approach was reported for vestibular
nerve section in 1904 (House and Shelton 1992). The primary indication for the middle fossa
approach in VS surgery is a small tumor that is confined to the IAC or protrudes only slightly into
the posterior fossa (House and Shelton 1992), but Wiegand (1989) has extended those criteria to
larger tumors. This route allows the removing of laterally placed tumors with visual control,
preservation of hearing, preservation of function of the facial nerve, avoidance of injury to the brain
stem or cerebellum, a minimal amount of vertigo, and a low postoperative morbidity (House and
Shelton 1992, House and Graham 1973). With the middle cranial fossa approach there is a small
recess at the fundus that cannot be exposed (Haberkamp et al. 1998).
Many authors (Shelton 1992, Fisch 1970, Glasscock 1969, House 1961) favor the use of
the middle cranial fossa approach.
Middle fossa  approach (Shelton 1992). During the operation the patient is placed in the supine
position with head turned to the side. The incision is in the pretragal area extending superiorly in
a gentle curve fashion. An approximately 2.5 cm square craniotomy located two-thirds anterior
and one-third posterior to the external auditory canal, is made.
The dura from the floor of the middle fossa is elevated. The middle meningeal artery is the
initial landmark, marking the anterior extent of the dissection. The dural dissection proceeds in a
posterior and anterior fashion. The petrous ridge is identified while avoiding injury to the
petrosal sinus. The arcuate eminence and greater superior petrosal nerve are identified; they are
the major landmarks to the subsequent intratemporal dissection.
After the dura is elevated, a retractor supports the temporal lobe. The blue line of the
semicircular canal is identified by drilling at the arcuate eminence. The greater superior petrosal
nerve medial to the middle meningeal artery is followed posteriorly to the geniculate ganglion.
The labyrinthine portion of the facial nerve is medial to the ganglion. Bone is removed from the
superior surface of the IAC down to the porus acusticus  internus. The lateral end of the IAC is
dissected. The dura of the IAC is divided along the posterior aspect. The facial nerve is followed
in the anterior portion of IAC. The superior vestibular nerve is cut at its lateral end and
vestibulofacial anastomotic fibers are divided. The tumor is separated from the facial and
cochlear nerves. The inferior vestibular nerve is divided, and the tumor is gently freed from the
lateral end of the IAC. The tumor is then separated from the cochlear and facial nerves and
removed. The internal auditory artery is preserved if hearing is to be preserved.
2.4.2.  Nonsurgical management
Conservative management. Improved diagnostic screening with MRI and also a better informed
population have resulted in the diagnosis of smaller and even nonsymptomatic VS (Selesnick et al.
1999, Rosenberg 2000). Surgical removal may pose a risk for complications requiring a
conservative management strategy (Nedzelski et al. 1992, Fucci et al 1999, Rosenberg 2000). This
policy assumes that according to its pattern of growth the tumor will not result in either mortality
or significant morbidity within the expected life span of a given patient (Levo et al. 1997).
Rosenberg (2000) advises that the majority of the VS patients over 65 years of age do not require
intervention. The indication for an intervention should be based on a combination of tumor growth
pattern and the severity of symptoms (Rosenberg 2000).
Stereotactic radiosurgery. Stereotactic radiosurgery or gamma knife radiosurgery was first time
used to treat VS patient in 1969 (Leksell 1971) at the Karolinska Institutet in Stockholm, Sweden.
In stereotactic radiosurgery intracranial targets are destroyed using single high dose of focused
ionizing radiation. Radiation is administered using stereotactic guidance (Leksell 1969). Tumor
growth control was achieved, but incidence of facial or trigeminal dysfunction was also apparent
(Pollock et al. 1998). MRI, improvement of dose-planning software and the gradual reduction of
radiation dose are important changes in VS radiosurgery (Pollock et al. 1998). The development of
a Linac-based system, in which multiple radiation arcs are used to cross-fire photon beams at a
target defined in stereotactic space, has improved the accuracy and precision of dose delivery
(Niranjan and Lundsford 2000), although also the cost is higher. Although surgery is the treatment
of choice for most patients with VS, radiosurgery can be good alternative for those with tumor
recurrence (Pollock et al. 1998) or with bilateral tumors (Poen et al. 1999).
2.5.  Outcome
Cushing (1917) described his mortality rates: “after the first operation the surgical mortality was
100%. After the first 10 cases it was lowered to 40%, after 15 cases it had dropped to 33.3%,
after 20 cases to 30%, after 25 cases to 24%, and after 30 cases to 20%; and it must continue to
fall until it drops to 10 or to 5% or better, even though the total figures must carry the burden of
early inexperience.”
Microscopic VS surgery when performed by well-qualified surgeons is associated with
relatively low morbidity and mortality rates (Irving et al. 1995, Wiet et al. 1992). With
microsurgical technique and modern anesthesia, mortality has fallen from 20% (Hardy et al. 1989).
In the 1950s mortality rates were 16% and normal facial nerve function rates 3% (Irving et al.
1995). In 1985 postoperative mortality was 5%, all among patients with large tumor (Welch and
Dawes 1985). In 1995 the mortality was reported to be 2-3% with normal facial function in 48-
67% of the patients (Irving et al. 1995).
House and House (1964) reported three major complications: hemorrhage (4.9%),
meningitis (5.7%), and cerebrospinal fluid leak (9.4% required secondary surgical closure), the
mortality being 5.4%. Although the permanent complication rate is very low, cerebrospinal fluid
leakage can occur in up to 20% of patients, the majority owing to poor intraoperative identification
of exposed air cells within the temporal bone (Wackym et al. 1999). In the patient series of Hardy
(1989) 13% of the patients had CSF leakage, part of them developing meningitis (Hardy et al.
1989).
The quality of life after VS surgery is an important measure of outcome of surgery,
although various results of facial nerve function following surgery suggest that an increase in tumor
size increases morbidity, and that postoperative facial nerve function directly relates to tumor size
(Irving et al. 1995). The patient’s perspective has been considered in only a few studies (Irving et
al. 1995). Poor outcome appears to be relatively independent of the age of the patient according to
Irving et al. (1995), and age alone should not be considered a contraindication to surgery.
Complete tumor removal. According to Welch and Dawes (1985) complete tumor excision with
suboccipital operation was possible in 84% of the patients with no recurrences seen in 5 to 7 years.
In 1989 Hardy et al. reported 3 perioperative deaths among 100 TL operations, and the
postoperative morbidity was low. Complete tumor excision was achieved in 97% and no
recurrences were seen during follow up of 1 to 7 years (Hardy et al. 1989).
A question of debate is subtotal tumor removal (Wiet et al. 1992). Subtotal removal has
been used in patients with advanced age or in those who wish to decrease complication risks
associated with the VIIth cranial nerve (Wiet et al. 1992). Lownie and Drake (1991) found a
recurrence rate of 18%. The surgical route can impose anatomic limitations (Wackym et al. 1999).
Incomplete tumor removal especially within the IAC is possible after suboccipital or
translabyrinthine resection (Wackym et al. 1999). With the retrosigmoid approach Haberkamp et
al. (1998) had a recurrence rate of 2.4%, compared with 44% for El-Kashlan et al. (2000) after
incomplete resection.
Facial nerve. Historically, discussion of postoperative morbidity has focused on complications
such as meningitis, cerebrospinal fluid leaks, intracranial hemorrhage, cerebral vascular accidents,
and compression injuries (Driscoll et al. 1998). With improvement of surgical management
mortality has dropped under 2%, the facial nerve is routinely saved, and hearing preservation is
obtained in selected cases. Thus quality of life issues such as dysequilibrium, headache, and
depression become more important (Driscoll et al. 1998).
Anatomical preservation of the facial nerve with complete tumor removal, especially in
patients with large tumors, is still a challenge (Wiet et al. 1992). Facial nerve monitoring has
greatly aided separation of the facial nerve from the tumor (Wiet et al. 1992). When 10% of the
functioning motoneurons are intact normal facial nerve function is preserved (Axon and Ramsden
1999). In a study by Hardy et al. (1989) the facial nerve was preserved in 82% of the 98 patients
with intact nerve preoperatively, and postoperatively 77 patients assessed their life quality to be
excellent (Hardy et al. 1989).
The results of postoperative facial nerve function in VS surgery from different surgical
teams in Helsinki University Central Hospital (Fig. 3) show the time before the operating
microscope era, and the time with facial monitoring (Blomstedt, unpublished data).
Figure 3. Postoperative facial nerve function after vestibular schwannoma surgery from three
different surgical teams in Helsinki University Central Hospital.
(* = House- Brackmann scale (House and Brackmann 1985)
The facial nerve is sometimes severed during the removal of VS, either intentionally to
ensure complete tumor removal, or unintentionally because of difficulties in identification of the
nerve. The risk for permanent facial paralysis increases with the size of the tumor (Harner and
Ebersold 1985). In a study by Jääskeläinen et al. (1990) altogether 36 facial nerves out of 219
patients were severed during years 1979 to 1987. Twenty-five facial nerves were cut intentionally
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to ensure complete tumor removal, and 11 unintentionally because of difficulties in identification.
Ramsay and Blomstedt (1999) studied the results of 90 adherent tumors. They left remnants of
tumor on the facial nerve in order to preserve the facial anatomical integrity of the nerve.
Functionally 94% of the patients had House-Brackmann grading IV or better postoperatively and
regrowth occurred in 9% of the cases (Ramsay and Blomstedt 1999). Eighty-five percent out of 48
patients had normal facial funtion immediately after operation according to Aitasalo et al. (1999).
Figure 4. The preservation percentage and recovery of facial function after vestibular schwannoma
surgery during years 1990 to 1993 in Helsinki University Central Hospital.
(* = House – Brackmann scale)
Recovery of the facial nerve after surgery was followed during years 1990 to 1993 (Fig. 4)
in Helsinki University Central Hospital (Blomstedt, unpublished data). Although facial nerve,
neuromonitoring, and the postoperative outcome of facial nerve were not in the scope of the
present study the outcome of facial nerve was analyzed and used in different outcome analysis to
evaluate dependencies between various factors, such as postoperative headache, recovery of
postoperative stability and hearing preservation.
Hearing preservation. In VS surgery hearing can be preserved using either the retrosigmoid
(suboccipital) or the middle fossa approach (Shelton 1992) (Table 1).
Preoperative criteria for choosing patients for hearing preservation vary (Shelton 1992).
Some authors propose that the risk for morbidity is too high compared to low likelihood of success
(Tos and Thomsen 1982). Most surgeons consider the limit for hearing preservation in the RS
approach being tumor size less than 2 cm (Glasscock et al. 1987) and in middle cranial fossa
approach less than 1.5 cm (Sanna et al. 1987). Intraoperative auditory nerve monitoring during
surgery is useful for hearing preservation (Shelton 1992), although the absence of an ABR at the
end of the surgery does not always mean that hearing preservation has failed (Ojemann et al. 1984).
Measurable postoperative hearing remains in 12 to 65% of patients (Shelton 1992). Hearing
preservation in cases of bilateral tumors, which tend to be more invasive than unilateral ones and
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tend to involve the cochlear nerves, is difficult (Bance and Ramsden 1999), but is not impossible
(Samii and Matthies 1997, Glasscock et al. 1987).
Table 1. Hearing preservation after vestibular schwannoma surgery surgery according to the
literature.
Year Patients Approach Tumor size Hearing preserved
(number) (mean)
____________________________________________________________________________________
Harner et al 1984 119 MCF 17mm 12%
Palva et al 1985 30 RS <20mm 43%
Silverstein et al 1985 13 RS 38%
Kemink et al 1990 20 RS 15.5mm 65%
Hoehmann 1991 41 MCF 17<10mm, 22 10-20mm, 46%
2>20mm
Cohen et al 1993 146 RS 10.2mm 26%
Glasscock et al 1993 MCF, RS
unilateral 136 49 IC, 75<10mm,12<20mm 35%
bilateral 22 9 IC, 13<10mm, 3<20mm,1>20mm 44%
Dornhoffer et al 1995 93 MCF (65<5mm, 11 5-10mm, 58%
17 10-15mm)
Umezu et al 1996 51 RS transmeatal 15.7 mm/22.8 mm 41.2%
Samii and Matthies1997 732 RS 39.5%
Kanzaki et al 1998 94 MCF 6.9 mm 50%
Ishikawa et al 1998 43 MCF 1 IC, 18<10mm,10 10-20mm, 41%
10>20mm
Slattery et al 1998 18 MCF 11mm 65%
____________________________________________________________________________________
Abbreviations: MCF = middle cranial fossa, RS = retrosigmoid, IC = intracanalicular
Contralateral hearing. Contralateral hearing loss after surgery is a rare complication that can
have immediate or delayed onset (Wiet et al. 1992). It has been reported to occur in the recovery
room, during the first postoperative week, months after surgery and several years after surgery
(Greiner et al. 1971, Clemis et al. 1982). Harris et al (1985) have proposed that sympathetic
cochleolabyrinthitis may occur in up to 1.3% of the patients.
Postural stability. Vertigo and imbalance postoperatively may be caused by vestibular or
cerebellar dysfunction (Wiet et al. 1992). Vestibular disability may persist in elderly patients (Wiet
et al. 1992). According to Wiet et al. (1992) most of VS arise from the vestibular nerve, and
therefore vestibular function has already been considerably reduced or even totally lost before
surgery and immediate postoperative vertigo is usually minimal. It is also thought that if
postoperative imbalance does occur from absence of vestibular compensation, it is usually transient
and diminishes within some weeks, and although it may persist longer in some older patients, it
seldom causes significant disability (Wiet et al. 1992) (Table 2).
Table 2. Postoperative balance problems after vestibular schwannoma surgery reported in the
literature.
Year Patients Approach Balance problems
(number)
______________________________________________________________________________
Magnusson et al 1991 57 TL stiffness increased with
eyes open
Parving et al 1992 273 TL 56% dizziness 6 months 
after surgery
Jorgensen and Pedersen 1994 46 TL 30 out of 44 vertigo
13 RS 8 out of 9 vertigo
Pyykkö et al 1994 224 RS/TL 41% slight postural 
instability
41% moderate postural
instability
3% could not walk
without help
van Leeuwen et al 1996 134 TL/RS more vertigo after TL
Rigby et al 1997 130 TL,RS,MCF 14.3% balance troubles
Andersson et al 1997 141 TL 45% balance problems
19% dizziness
Driscoll et al 1998 210 RS 31% balance problems
Lynn et al 1999 237 RS 65% balance problems
________________________________________________________________________
Abbreviations: TL = translabyrinthine, RS = retrosigmoid, MCF = middle cranial fossa
Headache. Severe postoperative headache is associated with VS surgery (Vijayan 1995, Schessel
et al. 1992) and it may be related to surgical bone debris in the subarachnoidal space, residual
intracranial air, or a transient elevation in intracranial pressure (Wiet et al. 1992).
Postoperative headache can be very severe in nature and last for many years after surgery.
Despite the use of nonsteroidal anti-inflammatory drugs or even narcotic analgesics the headache
may be persistent (Hanson et al. 1998). Many studies have confirmed a high incidence of headache
(Table 3.) and some have also postulated possible mechanisms and means of prevention with varied
degrees of success (Hanson et al. 1998).
Table 3. Postoperative headache after vestibular schwannoma surgery according to the literature.
Year Patients Approach Headache
(number)
_______________________________________________________________________________
Parving et al 1992 273 TL 29%
Cohen et al 1993 146 RS 14.3%
Schessel et al 1992 58 RS 64%
40 RS 67% (sigmoid incision, craniectomy)
13 RS 69% (triradiate incision, craniectomy)
19 RS 5% (triradiate incision, craniotomy)
Harner et al 1993 331 RS 9% (two years postoperatively)
Harner et al 1995 24 RS 4% (cranioplasty)
24 RS 17% (no cranioplasty)
Pedrosa et al 1994 155 RS 73%
TL 53%
Vijayan 1995 280 75%
van Leeuwen et al 1996 134 TL/RS more pain after RS
Ruckenstein et al 1996 18 TL no difference between TL and
35 RS SO groups one year postoperatively
Catalano et al 1996 84 RS 64% (excision)
81% (excision and cranioplasty)
10% (excision, cranioplasty, residue trapping)
Andersson et al 1997 141 TL 22%
______________________________________________________________________________
Abbreviations: TL = translabyrinthine, RS = retrosigmoid
3.  PURPOSE OF THE STUDY
The purpose of this study was to characterize the postoperative outcome of patients operated on
for VS and to evaluate some quality of life aspects of VS patients after surgery. The specific aims
were:
1. To characterize the frequency, type, and severity of postoperative headache in a retrospective
study of patients after VS removal with special reference to possible risk factors and
recovery.
2. To study the etiology of postoperative headache with special reference to vestibular function.
3. To evaluate the occurrence of hearing loss in the contralateral ear following cerebellopontine
angle tumor surgery through the TL and the RS approach.
4. To evaluate the usefulness of preserved hearing including the role of tinnitus, and to evaluate
pre- and postoperative factors predicting successful outcome in hearing preservation.
5. To evaluate postural stability after VS removal.
4.  MATERIAL AND METHODS
4.1.  Patients
The main study group consisted of 384 patients with unilateral or bilateral VS operated on during
years 1979 to 1994 in Helsinki University Central Hospital (Table 4.). In addition, 97 unilateral VS
cases operated on during the years 1978 to 1988 at Sahlgrenska Hospital, Gothenburg, Sweden
were also included in one part of the main study.
Table 4. Patient data (N = 348) of vestibular schwannoma patients operated on during years 1979
to 1994 in Helsinki University Central Hospital.
Bilateral / Unilateral 19 / 365
Operation route (retrosigmoid /    translabyrinthine) 348 / 36
Tumor size (mm) mean 22.0 (range 3-58 mm)
Age (years) mean 47.7 (range 7.9-73.4 years)
Gender (Male / female) 158 / 226
Operation radicality (yes / no) 325 / 59
Follow up time (years) 8.9 (range 1-16 years)
Tumor side (right / left) 178 / 206
.
Study I included charts from 359 patients. A questionnaire, based on the McGill Pain
Questionnaire (MPQ) (Melzack 1975, Melzack 1987) and the Finnish Pain Questionnaire
(Ketovuori and Pöntinen 1981, Ketovuori et al. 1984), was mailed to 317 patients with unilateral
tumor, and altogether 251 (79.2%) responded. Ninety-two patients out of these 251 reported
having postoperative headache, but only 27 patients considered it a major problem. These 27
patients, 11 men and 16 women, were entered further into Study II.
Study III consisted of 364 patients with unilateral VS. In addition, a survey was performed
on cases operated on during the years 1978 to 1988 at Sahlgrenska Hospital, Gothenburg, Sweden.
There were altogether 114 patients of whom 97 had unilateral VS, 14 cerebellopontine angle
meningeoma and 3 bilateral tumors. Only the 97 patients with unilateral cerebellopontine angle
tumors were included. All cases with postoperative hearing loss of contralateral ear exceeding 20
dB HL were evaluated (n = 9).
Study IV included 119 unilateral VS patients in whom the cochlear nerve was preserved in
order to preserve hearing.
In Study V the retrospective group consisted of 177 patients with unilateral VS operated
on during 1979 to 1987. The RS approach in the sitting position was used in 166 patients, and TL
approach in the supine position in 11 patients. Active postoperative habituation was started in
1988, and the prospective group consisted of 44 patients with unilateral VS operated on after
1988. In 40 patients the approach was RS in the lateral recumbent position and in 4 patients TL in
the supine position.
4.2.  Methods
The intensity of postoperative headache was expressed using the Visual Analogue Scale (VAS)
ranging from “no pain“ (0) to “worst possible pain“ (100) (Huskisson 1974). The scale is a 10 cm
long line and patients choose the intensity of their headache between the two points “no pain” ja
“worst possible pain”. The number of words chosen in the MPQ or more clearly in the Finnish Pain
Questionnaire (Ketovuori et al. 1981) was also used to characterize pain intensity (Melzack 1975).
Using a VAS, the patients were grouped into the categories of “no or slight headache“ (VAS<3.3
cm), “moderate headache“ (VAS between 3.3 and 6.6 cm), or “severe headache“ (VAS>6.6 cm).
The tinnitus questionnaire was based on the Tinnitus Handicap Questionnaire (Tyler et al.
1989, Kuk et al. 1990). The hearing questionnaire was based on the Social Hearing Handicap
Index (Ewertsen and Birk-Nielsen 1973) (see Appendix).
Pure-tone audiograms and speech audiometries were performed to evaluate hearing.
The Vestibulo-ocular reflex (VOR), producing compensatory eye movements during head
movements in the operative frequency range of 0.1 to 5 Hz (Juhola et al. 1997), was evaluated
with the Vestibular Autorotation Test (VAT). In the VAT the patient is asked to rotate his or her
head 10 degrees from side to side in pace with a sound signal while gazing at a stationary red spot
on the wall 150 cm to the front (Hirvonen et al. 1995). The head movement accelerates gradually
over 20 seconds from 0.5 Hz to as fast as possible (about 5 Hz). The VOR is measured at different
frequencies; the highest frequency reached and also the gain and phase shift values are measured.
Gain is computed for each sine wave of the signals as the ratio of the eye movement amplitude and
the head movement amplitude. The phase shift is computed between the maxima or minima of the
sine waves of the eye and head movement signals.
In posturography the force platform is constructed according to the strain gauge principle
(Aalto et al. 1988). The vertical force distribution over the platform surface is measured and the
coordinates of the center point of the force in the forward-backward and lateral directions are
measured and analyzed. The posturography measurement lasted for 180 seconds. Stabilograms are
recorded during two tests, one with (eyes open) and one without (eyes closed) visual control. The
program calculates the sway velocity (SV). The Romberg quotient (RQ) describes the ratio
between SV with eyes closed and SV with eyes open.
Postural perturbation is induced with vibrators, bilaterally on the calf muscles or on the
neck muscles. Vibration is generated by means of a revolving DC motor (Escap, Switzerland) with
a 5 g unbalanced weight at one end. The vibrator is built in a metal cylinder, length 50 mm and
diameter 18 mm. Varying the input voltage of the DC motor controls the frequency of the
vibration. The waveform of the vibration is sinusoidal. Eklund (1971) has provided a detailed
description of this kind of vibrator system. Frequencies of 20, 40, 60, 80 and 100 Hz are used and
delivered in pseudo-random fashion. The stimulator unit is controlled with a microcomputer
(Hewlett Packard 75 C). The amplitude of the vibration is 0.4 mm (peak-to-peak) and is constant
at all frequencies when measured unloaded. Two vibrators were held firmly against the calf muscles
or the neck muscles with straps. The Proprioceptive index is the ratio between the SV during
vibration perturbation on the calf muscles at 80 Hz and the baseline SV, both with eyes closed.
During the testing of the 27 patients with POH the headache was provoked with both the
VAT and the posturography measurement. When the headache occurred the patient was given
100mg sumatriptan.
4.3.  Statistical methods
In Study I the variables characterizing the patients’ headache were analyzed by a factor analysis
using simple correlation and varimax rotation. To find variables suggesting a risk of postoperative
headache a linear discriminant function analysis and logistic regression analysis were used.
Duncan’s multiple range test was used to compare the groups.
In Study II the Chi-square test with Yates correction was used for comparing the maximal
frequency in the VAT. For the continuous variables of the VAT and the posturography, an analysis
of variance was used, and the differences were gauged with Bonnferoni’s test.
In Study IV linear regression analysis was used for the comparison between the outcome of
various factors influencing the success of hearing preservation. Stepwise logistic regression analysis
was used when evaluating factors determining the outcome of hearing preservation surgery. In
studying internal correlations Kendall’s linear correlation analysis was used. Student’s t-test was
used for the statistical calculations between the groups of patients.
In Study V factors influencing the postural stability were assessed with linear regression
analysis and logistic regression analysis. The patients and controls were compared with Student's t-
test.
4.4.  Ethics
The ethics committee of Helsinki University Central Hospital approved the present study
(KO11/94, KO 41/95).
5.  RESULTS
5.1  Postoperative headache (I)
Headache that commenced only after surgery was regarded postoperative headache (POH). In the
results the subjects with headache were classified into two groups: the POH group and those with
preoperative and postoperative headache, the prePOH group.
The patients with postoperative headache experienced their headache mainly in the area of
the neck (71%) and the occiput (76%) regardless of the surgical approach. In both groups the pain
was typically unilateral and felt on the side of the surgery. The changes of postoperative headache
after surgery in both prePOH and POH groups is shown in the Figures 5 and 6. The severity of the
postoperative headache declined more among the POH patients than among the prePOH patients
(X2, p<0.05). (I)
Figure 5. Continuing headache among the patients with headache pre- and postoperatively
(prePOH) and among the patients with no headache preoperatively (POH) (N = 251).
The model consisting of preoperative headache, surgical approach, postoperative gait
disorders, and tumor size predicted headache postoperatively for 68.1% of the patients, and was
statistically highly significant (p<0.001) when analyzed with logistic regression analysis. The
surgical approach (p<0.05) was the most important single risk factor linked to severe postoperative
headache, the odds ratio (OR) being 3.9 for the retrosigmoid approach. Preoperative headache was
also a statistically significant risk factor (p<0.05) for postoperative headache (OR 2.5), and
postoperative gait disorders increased the probability of postoperative headache (OR 2.4, p<0.05).
Also small tumor size was a risk factor (OR 1.1, p<0.01).
When only the patients with postoperative headache were studied, the logistic regression
analysis showed that the surgical approach (RS) was the single most important risk factor for
postoperative headache (OR 5.8, p<0.05).
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Figure 6. Maximum pain 1 year after operation  and a mean of 8.9 years after operation. Patients
with postoperative headache are grouped as those with headache preoperatively (prePOH) and
those with no headache preoperatively (POH). N = 251.
5.2.  Postoperative headache (II)
All 27 patients with severe headache were able to carry out the VAT; there was no difference in
performance among patients with or without headache. The difference in gain was significant
between the patients and normal controls (p<0.01).
Body sway in posturography was significantly increased among the patients with headache
during the baseline stance, and during the vibration of neck muscles, when comparing the patients
with the healthy controls (p<0.01). No differences were observed between the patients with and
without headache.
After anesthetising the neck muscles, 25 patients were able to rotate their head at a
frequency of 1 Hz, 17 at 3 Hz and 7 patients at 4 Hz. All 9 normal controls reached 4 Hz (Fig. 7).
Of the 27 patients 26 reported headache during the three days of testing and provocation,
only one experiencing no pain or discomfort at all. In the 26 patients in whom headache occurred
100mg sumatriptan alleviated pain in 9 patients and completely abolished the pain in 1 patient.
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Figure 7. Highest performed VAT (percentage) frequencies after neck muscle anesthesia. Results
of vestibular schwannoma patients with headache and the normal controls.
5.3.  Cochleolabyrinthitis (III)
Altogether 478 patients with VS or cerebellopontine angle meningeomas were studied, 32 of
whom were operated on using the TL approach and 446 the RS approach. Two patients with the
TL approach developed vertigo and prominent hearing loss in the contralateral ear (Table 5). The
hearing loss started within two weeks of the surgery. Eight patients with the RS approach
developed a significant hearing loss of the contralateral ear that started two to four years after
operation, and in three patients this was identical to delayed hydrops (Table 5).
Table 5. The development of cochleolabyrinthitis. Contralateral hearing loss, tumor size and
vertigo in patients with removed vestibular schwannoma and one cerebellopontine angle
meningeoma.
Case Operation
route
Mean
tumor size
(mm)
Preop.
HL
(dB)
Post-op
HL
(dB)
Time to
onset of HL
Onset and course of
HL
Vertigo
1 TL 30 7 35 1 week fast, stabilized yes
2 TL 13 10 50 2 weeks fast, stabilized yes
3 RS * 17 90 4 years fast, progressive no
4 RS 25 15 55 2 years fast, fluctuant yes
5 RS 10 10 45 2 years fast, fluctuant no
6 RS 27 10 35 2 years fast, fluctuant yes
7 RS 37 7 30 2 years slow, fluctuant no
8 RS 27 10 47 5 to 7 years slow, progressive no
9 RS 35 15 35 3 to 6 years slow, stabilized no
10 RS 30 12 35 3 to 6 years slow, stabilized no
TL = translabyrinthine, RS = retrosigmoid, * = meningeoma
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5.4.  Hearing preservation (IV)
Hearing was preserved in 47 out of 119 patients (Table 6). In 10 patients with preserved hearing
tumor size was larger than 15 millimeters. Ten patients had hearing better than 30 dB. Hearing was
followed on average 7.3 years, range 1 to 16 years. There was gradual deterioration (about 5 dB)
during the follow-up time. Hearing was lost in four patients during the follow up period (three
months, one year, and  in two patients two years after surgery).
Table 6. Vestibular schwannoma patients grouped to those with and without successful hearing
preservation surgery.
Cochlear nerve intact
Factor
Hearing lost  n = 72 Hearing preserved
n = 47
Mean age (yr) 45 49.2
Mean tumor size (mm) 15.0 12.6
Mean preoperative PTA (dB
HL)
37.1 31.0
Mean preoperative
Discrimination (%)
76.2 82.9
Mean postoperative PTA (dB
HL)
>120 54.7
Mean postoperative
Discrimination (%)
0 64.6
Mean facial function* 1.3 1.1
* = House and Brackmann scale, PTA = pure tone average, HL = hearing level
The model for predicting successful hearing preservation consisted of age, tumor size,
PTA, SDS and hearing level at 1000 Hz in pure-tone audiometry (p<0.003). In the model age
(p<0.008) and SDS (p<0.06) were the strongest predictors for preserved hearing. Tumor size,
PTA and hearing at 1000 Hz did not reach the level of statistical significance. During surgery the
interface between the nerve and the tumor seemed to be the most important factor for hearing
preservation, an easily identifiable cleavage plane enabling less traumatic tumor removal.
Table 7. Vestibular schwannoma patients’subjective evaluation of the usefulness of their preserved
hearing.
Rating scale
Usefulness of hearing
preservation*
(n=39)
Hearing
of sound
(n=39)
Speech
discrimination
(n=39)
Sound
localization
(n=39)
None 8%      (16dB / 97%) 8% 15% 28%
Undecided 20%   (10dB / 100%) 26% 23% 23%
Some 23%     (3dB / 100%) 20% 21% 15%
Moderate 13%      (3dB / 97%) 13% 18% 21%
Very 36%     (11dB / 97%) 33% 23% 13%
*=Mean contralateral PTA / SDS
PTA = Pure tone average hearing level, SDS = Speech discrimination scores
The questionnaire indicated that 70% of the patients found their preserved hearing useful or
very useful (Table 7). Sound distortion was not experienced to be a problem in the majority of the
patients (65%), but was distressing in 15%. Tinnitus was present in 68% of the patients. It
localized to the tumor ear in all but 2 patients. Table 8 shows the subjective handicap caused by
tinnitus.
Table 8. Subjective disability, and use of sleeping pills due to tinnitus according the vestibular
schwannoma patients with preserved hearing.
Rating severity of
tinnitus
Subjective
disability
(n=39)
Interference with
sleep
(n=39)
Use of sleeping
pills
(n=39)
No tinnitus 38% 38% 38%
Very mild 5% 38% 54%
Slight 33% 21% 8% (occasionally)
Moderate 21% 3% 0 (weekly)
Severe 3% 0 0 (every night)
5.5.  Postural stability (V)
In the retrospective study 122 out of 177 patients considered their moving ability normal, 27 had
slight difficulties, 7 needed a cane, 3 were able to move only with human support and 1 patient was
totally unable to walk. Postural stability, based on posturography measured 5 or 7 years after
surgery, was normal in 122 patients (69%) under visual control and in 67 patients (38%) under
non-visual control (Fig. 8). Vibration in non-visual control increased body sway more than in visual
control (p<0.001).
Figure 8. Sway velocity under visual and non-visual control among the patients in the prospective
and the retrospective groups, and among normal controls.
In the prospective patient group, under visual control 30 patients (68%) had normal
postural stability on posturography one year after the operation. Under non-visual control 23
patients (52%) had normal postural stability. The difference between the retrospective and the
prospective patient groups regarding SV was statistically significant (p<0.05) under non-visual
control (Fig. 8).
Figure 9. Sway velocity (cm/s) both with visual- and non-visual control measured preoperatively
and during the first postoperative year. The prospective patient group. (N = 44)
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The changes in the mean SV before and after operation under visual and non-visual control
are shown in  Figure 9. Three months after surgery the mean SV had returned almost to the
preoperative value; however, one year after surgery the mean SV was still not better than the value
before surgery.
The retrospective and prospective groups were combined to study the role of the postural
active habituation and surgical position for outcome of postural recovery. In the logistic regression
analysis the surgical position and habituation are heavily intercorrelated as both changes took place
at the same time. With gait problems the model consisting of surgical position (p<0.01), gender
(p<0.01), and outcome of posturography (p<0.001) as the independent variables was statistically
significant and could explain 65% of the variance of the gait problems. The odds ratios for surgical
position and female gender were 6 and 2.5, respectively, making them the most important risk
factors for poor postural stability.
The role of proprioception and visual control as compensatory vestibular mechanisms was
also studied. A high proprioceptive index indicates relative reliance on the former (p< 0.001), and a
high Romberg quotient on the latter (p<0.001). Those who relied more on proprioception fared
better than those who relied on visual control.
6.  DISCUSSION
In the present study we examined headache after vestibular schwannoma surgery. If headache was
present before the operation it tended to continue also postoperatively, although 20% of patients
who had headache preoperatively did not complain of headache postoperatively. Sixty (23.9%)
patients developed POH without preoperative headache. Headache declined during the first year
after operation, but if it persisted for a year, it seemed to become permanent.
There was no difference in vestibular function when the POH patients were compared with
VS patients without POH. Differences were not observed between these groups in vestibulo-ocular
or vestibulo-spinal reflexes, either. Therefore the POH may not be explained by the vestibular
imbalance. The postoperative headache, although probably multietiological, may be caused by
trigeminal neuropathy in the posterior fossa, where pain afferents trigger abnormal reflexes
mimicking local vascular headache (Vass et al.1997, Vass et al. 1998). Bone dust irritation or
manipulation of the sensitive duro-periosteal complex may cause this trigeminal neuropathy.
Ten out of 478 patients in study III developed hearing impairment of the non-operated side:
two patients directly after TL operation (6%) and eight patients after RS operation (1.8%) with a
late onset. One explanation could be AID (autoimmune inner-ear disease) (Hariri 1993). The
contralateral hearing loss in the RS cases with an intact labyrinth might be due to the removal of
the endolymphatic sac. It is therefore speculated that even in the RS cases, AID may be the reason
for contralateral hearing loss.
In the present study hearing was preserved in 39% of  patients in whom the cochlear nerve
was preserved. The result is very similar to that of other studies (Cohen et al. 1993, Samii and
Matthies 1997). Four patients (8.5%) with preserved hearing later experienced significant hearing
impairment. Similar impairment has been reported to occur in other series with the same frequency
(Shelton and House 1990). The preserved hearing was considered beneficial by 66% of the patients
contrary to the results of Tos et al. (1988), although the preserved hearing was better than 30 dB in
only 10 patients. Preserved hearing was perceived as valuable for speech discrimination during
conversation. We found that neither distortion of speech nor aggravation of tinnitus caused major
disability after surgery.
Vestibular compensation after removal of VS takes place during the first months after
surgery (Haid et al. 1991), even without active habituation (Mruzek et al. 1995). However, Lynn et
al. (1999) reported persistent dysequilibrium in up to 65% of patients. In the present series the
results of retrospective study showed that 69% of the patients considered their gait normal, while
in posturography only 32% had postural stability within normal limits, indicating that subjective
evaluation of gait and measured postural stability are evaluating different aspects of body
equilibrium. The impairment of postural stability was usually slight, as only four patients had severe
difficulties with postural stability.
The VS patients in present study were all in all quite satisfied with their postoperative
condition. Although headache was frequent for majority of the patients it was a minor complaint.
Only one patient had headache which did not relieve with any medication, but headache appeared
very seldom. Hearing preservation was experienced beneficial. The contralateral hearing loss was
rare. Patients did not complain of balance difficulties spontaneously, but they had motivation to
active postoperative habituation. Although the patients succeeded in their every day life, the
retiring tendency was apparent.
6.1.  Methodological aspects
The diagnosis of VS has changed during the last years considerably as MRI has become the most
preferred diagnostic tool (Möller 2000, Robinette 2000). The incidence of VS increases with age
(Möller 2000) and even tumors of only a few millimeters in size are diagnosed with MRI.
Nowadays the patients present with minor symptoms and smaller tumors than in the beginning of
the present study, which causes differences within the patient material. The total patient material in
this study is large, including all the VS patients treated at Helsinki University Central Hospital
during 1979 to 1994. The study was done in a tertiary center to which the most of the VS patients
in the southern Finland are referred. Mainly two operative methods were used, TL operation and
RS operation, although the group of TL patients was altogether small.
In a study by Blomstedt et al. (1991) in which the VS operations were done before the
operating microscope era, the mortality was quite obviously higher among VS patients than among
the matched general population during the first year after surgery, but after the first year the
mortality rates became equal (Blomstedt et al. 1991). In 1985 Welch and Dawes reported 5%
postoperative mortality, all among patients with large tumors. In 1995 Irving et al. reported a
postoperative mortality rate of 2-3%, and Guerin et al. in 1999 a rate of 0.3%. Even results with no
postoperative mortality have been reported (Jung et al. 2000, Lanman et al. 1999). NF2 patients
have a larger risk for postoperative mortality because of the more progressive tumor growth (Samii
et al. 1997). The development of the operative technique during the years of present study together
with the presenting smaller tumor size have influenced the postoperative results The tumor sizes
during years 1962 to 1973 and 1990 to 1992 were compared in Helsinki University Central
Hospital (Fig. 10).There are today about equally frequently giant tumors but fewer large and mid-
size tumors than at the early 70’s. The dominance is shifting towards small tumors. When the major
complications hemorrhage, meningitis, and cerebrospinal fluid leak are becoming rare, quality of
life issues such as dysequilibrium, headache, and hearing preservation are more important.
Figure10. The size of vestibular schwannoma during years 1962 to 1973 (N = 133) and 1990 to
1992  (N = 47) in Helsinki University Central Hospital.
Several questionnaires were used in present study. VAS (Huskisson 1974), MPQ (Melzack
1975), Finnish Pain Questionnaire (Ketovuori et al. 1981), Tinnitus Handicap Questionnaire (Tyler
et al. 1989, Kuk et al. 1990) and Social Hearing Handicap Index (Ewertsen and Birk-Nielsen 1973)
are all validated international questionnaires. Only the questionnaires concerning gait, depression,
and quality of life were not international.
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6.2.  Postoperative headache
Postoperative headache is usually connected with the SO or RS approach in surgery for VS
(Schessel et al. 1992), and up to 73% of patients suffering from POH have undergone the
suboccipital approach (Pedrosa et al. 1994).  The incidence of headache after the TL approach
varies in the literature from 0% (Schessel et al. 1992) to 75% (Vijayan 1995). In the present study
the incidence of headache after the TL approach was 39%. Thus none of the operative approaches
are without risk for headache, but in the present study the RS approach carried a 3.8 times higher
risk for headache than did the TL procedure.
Mechanical, electrical or chemical stimulation of the trigeminal sensory nerves may produce
neurogenic inflammation and intense head pain (Hargreaves et al. 1999). Vass et al. (1997, 1998)
demonstrated that the first branch of the trigeminal ganglion sends projections to the cochlea and
also to the dura of the posterior fossa (Keller et al. 1985). Vass et al. (1997) suggested that the
trigeminal sensory innervation of the cochlea plays an important role in cochlear blood flow
regulation. Stimulation of trigeminal perivascular nerve endings causes vasodilatation and edema
leading to further sensory nerve activation and neurogenic inflammation (Vass et al 1998).
Sumatriptan interacts with the trigemino-vascular system, possibly through direct cerebral
vessel constriction or through the inhibition of sensory neuropeptide release or both (Moskowitz
and Buzzi 1991). In present study one patient responded to sumatriptan with complete pain relief,
and nine others considered it helpful to some extent. The sumatriptan trial was not randomized and
therefore our observation is not reliable. However this result suggests that vascular structures may
be involved in at least some cases. More research is needed to solve the etiology of headache.
6.3.  Sympathetic cochleolabyrinthitis
AID can be induced experimentally by infection (Gloddek et al. 1992), trauma ((Jackson 1994) or
vaccination (Harris 1984). Recent animal models using immunization to inner ear extracts
(Gloddek et al. 1994) or adjuvant therapy (Harris 1984) indicate that the pathological changes in
the inner ear are characteristic of a disease like Ménière`s disease, with autoimmune cellular
response against the endolymphatic sac (Soliman 1996).
Sympathetic ophthalmia may be used as an analogy for sympathetic cochleolabyrinthitis. In
the recent literature the incidence of sympathetic ophthalmia varies between 0.2% and 0.5% among
subjects with a penetrating eye wound, although in the older literature an incidence as high as 16%
has been reported (Towler and Lightman 1996, Power and Foster 1996). After eye surgery the
incidence is significantly lower, being about 0.007% (Tower and Lightman 1996). The latency of
onset of sympathetic ophthalmia varies from 10 days to 50 years from the original traumatic
incident. In present study the onset of hearing loss after operation varied from 2 weeks to four
years.
A test to prove the presence of antibodies to inner ear proteins in affected patients, and
their absence from patients without contralateral hearing loss, is needed before the etiology of
sympathetic cochleolabyrinthitis can be confirmed.
6.4.  Hearing preservation
Hearing was preserved in 40% of the 119 attempted cases. The preservation of hearing was
considered a success by 66% of the patients, although in only 10 patients the preserved hearing
was better than 30 dB. There is controversy as to what should be considered useful, acceptable or
serviceable hearing (Shelton and House 1990). Usually when audiometric criteria are advocated, it
is said that the 50/50 rule should apply to serviceable hearing (Glasscock et al. 1983).  Our patients’
subjective evaluation of the usefulness of their residual hearing indicates that the levels are beyond
these limits, and there was no correlation between the measured PTA levels and speech
discrimination. The second general belief is that if the hearing level between the ears differs by
more than 20 dB the weaker ear does not aid in conversation (Glasscock et al 1983). It is also
claimed that leaving the cochlear nerve increases the risk of handicapping tinnitus (Harcourt et al.
1997). In 5 patients with a deaf ear and tinnitus, the non-functioning cochlear nerve was removed.
In 2 cases of them tinnitus was significantly relieved, but in 3 cases it was unchanged. This
experience has discouraged us from attempts to eliminate tinnitus by re-operation. Among the
patients with residual hearing tinnitus was a major problem in only one patient. Thus the argument
that leaving the cochlear nerve will worsen the tinnitus seems unfounded. The results of the present
study encourage surgeons to continue efforts to preserve hearing in VS surgery.
6.5.  Postural stability
Herdman et al. (1995) and Lynn et al. (1999) found no relationship between age and postural
instability after VS removal, but in their study the surgical approach in the experimental group was
TL (Herdman et al. 1995). Tumor size was not related to postural stability (Herdman et al. 1995,
Lynn et al. 1999) either,as was also found in the present study, also. In the present study elderly
patients showed increased risk for poor vestibular compensation. In these patients postural stability
is influenced by poor vision, diminishing of stretch reflexes, and changes in the vestibular part of
the labyrinth (Hytönen et al. 1993), which results in decreased adaptive capability.
Depression seems to be associated with VS surgery (Blomstedt et al. 1996). Postoperative
depression was associated with a significant risk for poor postural recovery. The reason remains
unclear. The RS approach had 6.8 times greater risk for poor postural recovery than the TL
approach. This may be linked to the sitting position in RS during which the cerebellum must be
firmly retracted and the subject is exposed to air embolism. The patients’ position during RS
surgery was changed to the supine in 1988.
Female gender was a risk factor for postoperative gait problems as shown in other studies
(Driscoll et al. 1998). Postural imbalance may be linked to reduction of estrogen levels with ageing
(Naessen et al. 1997). Postural balance is better preserved in long-term estrogen users than in non-
users (Naessen et al. 1997). In the present study the postmenopausal female patients did not use
estrogen, which may be one reason for the female patients being at risk for postoperative gait
problems.
The results of the present study show that not all of the VS patients compensate the
vestibular damage after VS surgery, and that they benefit from the use of vestibular active
habituation to improve their postural stability.
7.  CONCLUSIONS
1. At an average of 9 years after surgery, 93 out of 251 patients with headache postoperatively
still reported headache, which was a major problem for 27 of them. Headache declined during
the first year after operation, but if it persisted for a year, it seemed to become permanent. The
retrosigmoid approach, postoperative gait problems, preoperative headache and small tumor
size predicted problematic headache after surgery.
2. Vestibular imbalance or abnormal activation of neck muscles did not explain postoperative
headache. Occipital nerve entrapment or craniotomy-related dural retraction explained
headache in a few patients. POH was alleviated by sumatriptan in eleven of the 27 patients
with persistent headache. The sumatriptan effect may suggest a vascularly mediated trigeminal
neuropathy in the etiology of postoperative headache. Trigeminal irritation in the inner ear or
the posterior fossa may cause neurogenic inflammation mediated through vascular structures.
3. Contralateral hearing loss was observed to occur in 6% of the TL and 1.8% of the RS cases,
indicating that the TL approach may be related with more complications than are presently
known.
4. Hearing preservation was successful in 40% of the cases with intact cochlear nerve. Of those
patients 66% rated preserved hearing valuable. Neither tinnitus nor speech distortion were
considered disadvantageous for hearing preservation. The vascular structure of the inner ear is
possibly the most significant factor for hearing preservation.
5. After operation 69% of patients spontaneously regained normal postural stability in visual
conditions, but only 37% in non-visual conditions. Vestibular active habituation increased the
use of proprioception in mainteining postural control. Advanced age was a risk factor for poor
postural recovery. Female gender and surgical position were risk factors for postoperative gait
problems.
More research is needed to solve the etiology of postoperative headache. A test proving the
presence of antibodies to inner ear proteins in affected patients, and their absence from patients
without contralateral hearing loss is needed before the etiology of sympathetic
cochleolabyrinthitis can be confirmed. Hearing preservation is worthwhile after VS surgery.
Not all of VS patients can compensate for vestibular damage after VS surgery, but many
patients benefit from the use of active habituation to improve their postural stability.
Overall impression of the VS patients was satisfaction with postoperative condition in spite of
different minor or even major problems. Although the patients succeeded in their every day
life, the retiring tendency was apparent.
APPENDIX
The Social Hearing Handicap Questionnaire (Ewertsen and Birk-Nielsen 1973)
______________________________________________________________________________
1. If you are sitting opposite a person at a distance about 1 m, will you be able to understand
everything if the person speaks in a normal tone of voice?
 2. Do you have problems in understanding when members of the family are gathered together?
3. Is it difficult for you to hear in the kitchen when the water is running?
4. Do you find it difficult to hear what the shop assistant says to you?
5. Is it difficult for you to carry on a telephone conversation?
6. Can you follow the conversation when you are talking to several people?
7. Is it difficult for you to follow a conversation at a tea table with several persons?
8. Can you hear most of what is said when sitting at the back of  a lecture room, a theatre or a
church?
9. Can you carry on a conversation with someone sitting at the other end of the room and
speaking in a normal tone of voice?
10. Can you hear the radio well when it is set at normal volume?
11. Can you carry on a conversation easily in a car, tram or bus?
12. Can you carry on a conversation easily at the dinner table at home?
13. Do you understand what is said to you when there is noise from other voices, typewriters,
traffic, music?
14. Do you recognize persons by their voices?
15. Is it difficult for you to hear people speaking on TV when it is not turned up?
16. Is it difficult for you to follow a conversation at a large dinner table?
17. Can you carry on a conversation with someone when the radio or TV is not turne d down?
18. Is it difficult for you to carry on a conversation with someone in a busy street?
19. Is it difficult for you to understand what is said to you from an adjoining room?
20. Can you carry on a conversation with a person where there is noise, for instance at a
restaurant or at a party?
21. Do you often misunderstand other people’s conversation?
______________________________________________________________________________
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